LY6D, LY6E, PSCA, and PLAUR, known markers tumorigenesis and cancer cell maintenance, were significantly associated with lower overall survival outcome in our pancreatic cancer analysis [10, 11]. This evidence concerns the gene LY6D and familial pancreatic carcinoma.